Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 5, 2002, Pages 1216-1224

  Bubb, Robbin S ^a   Komaki, Ritsuko ^a,b   Hachiya, Tsutomu ^a   Milas, Ivan ^a   Ro, Jae Y ^a   Langford, Lauren ^a   Sawaya, Raymond ^a   Putnam, Joe B ^a   Allen, Pamela ^a   Cox, James D ^a   McDonnell, Timothy J ^a   Brock, William ^a   Hong, Waun K ^a   Roth, Jack A ^a   Milas, Luka ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b The University of Texas M D Anderson Cancer Center ^*  (United States)

Author keywords

bcl 2; Brain metastasis; Ki 67; Non small cell lung cancer; p53

Indexed keywords

BIOMARKERS; BRAIN; CELLS; CORRELATION METHODS; HISTOLOGY; PATIENT MONITORING;

METASTASIS;

TUMORS;

BIOLOGICAL MARKER; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; ASSOCIATION; BRAIN METASTASIS; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036680530     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02861-4     Document Type: Article

References (29)

1. Cancer statistics 2001
2. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma
3. The role of prophylactic cranial irradiation in the treatment of lung cancer
4. Long-term survival with metastatic cancer to the brain
5. Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission (Cochrane Review)
6. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group
7. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: Long-term follow-up and investigations of late neuropsychologic effects
8. Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis
9. Predicting the sites of metastases from lung cancer using molecular biologic markers
10. Tumor metastasis to brain: Role of endothelial cells, neurotrophins, and paracrine growth factors
11. Metastatic adenocarcinoma to the brain: An immunohistochemical approach
12. Mechanisms underlying invasion and metastasis
13. Tumor cell interactions with the extracellular matrix during invasion and metastasis
14. Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer
15. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer
16. Expression of p53 oncoprotein in non-small-cell lung cancer: A favorable prognostic factor
17. Bcl-2 protein in non-small-cell lung carcinoma
18. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: A meta-analysis
19. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
20. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression
21. A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers
22. Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer
23. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation
24. Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer
25. 67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas
26. Bcl-2 oncoprotein in surgically resected non-small cell lung cancer: Possibly favorable prognostic factor in association with low incidence of distant metastasis
27. Bcl-2 initiates a new category of oncogenes: Regulators of cell death
28. Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer
29. The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients